Kuhnil Pharm is a medium-sized, fully-integrated and family-owned pharmaceutical company that has been developing, manufacturing, and distributing since 1969. The core business of Kuhnil is dedicated to cardiovascular (CV), central nervous system (CNS), infectious diseases (IM), and antibiotics. Based on the performance Kuhnil has built up so far, the company is currently making every effort to grow as a global entity with differentiated research and development (R&D) as its main focus. This encompasses the development of new drug molecules, improved drugs with new dosage forms or innovative drug delivery systems (DDS), and new combination drugs.

Services include:
- Finished Dosage Forms
- Research and Development
- Contract Manufacturing
- Active Pharmaceutical Ingredients

Kuhnil Pharm is committed to advancing healthcare through its diverse range of pharmaceutical services and innovative solutions. For more information, please visit kuhnil.com.